Search for: "U.S. v. Treat"
Results 41 - 60
of 10,874
Sorted by Relevance
|
Sort by Date
29 Mar 2022, 8:34 pm
The case arose in an inter partes review (IPR) proceeding by challenger Amneal over Almirall's U.S. [read post]
18 Apr 2015, 5:13 pm
U.S.: Whether mere possession of a short-barreled shotgun should be treated as a violent felony under the Armed Career Criminal Act. [read post]
21 Jul 2022, 9:15 am
Last week, the U.S. [read post]
21 Jul 2022, 9:15 am
Last week, the U.S. [read post]
9 Aug 2012, 1:05 pm
AMREP Corp. v. [read post]
29 Sep 2020, 9:50 pm
Biogen asserted U.S. [read post]
28 Aug 2014, 9:29 pm
The Orange Book-listed patents-in-suit, U.S. [read post]
30 Jul 2019, 9:58 pm
Falk Pharma GmbH v. [read post]
25 Oct 2013, 7:30 am
By contrast, Plessy v. [read post]
28 Mar 2015, 8:24 am
” Young v. [read post]
7 Jun 2012, 12:37 pm
Tamraz v. [read post]
22 Jul 2017, 5:00 pm
The business character of the income of a partnership flows through to a partner, with the effect that a partner of a partnership with ECI treats its share of the income of the partnership as ECI (thus typically resulting in U.S. income taxation of that partner on its share of the partnership ECI.In 1991, the IRS put those principles into a bag, shook them up, and issued Rev.Rul. 91-32 which held that a partner with capital gain from the disposition of a partnership that is engaged… [read post]
11 Mar 2019, 5:55 am
National Australia Bank Ltd., 561 U.S. 247 (2010), and RJR Nabisco, Inc. v. [read post]
10 Nov 2015, 9:16 am
” Eli Lilly & Co. v. [read post]
11 Oct 2016, 6:43 am
McCarthy proceedings in the Ninth Circuit: (1) U.S. [read post]
14 Feb 2019, 9:50 pm
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
30 Dec 2019, 8:38 pm
§ 271(e)(2) of Orange Book-listed U.S. [read post]
16 May 2019, 8:55 pm
Patent No. 8,410,131 were obvious in a decision handed down this week in Novartis Pharmaceuticals Corp. v. [read post]
20 Aug 2019, 9:59 pm
The following claims were at issue in this litigation: Claim 11 of the '195 patent: A method of treating... [read post]
27 Jul 2016, 9:18 pm
Noonan -- The Federal Circuit affirmed the decision by the Patent Trial and Appeals Board (PTAB) in an inter partes review (IPR) that the claims of Genzyme's U.S Patent Nos. 7,351,410 and 7,655,226 were obvious, in Genzyme Therapeutic Products, Inc. v. [read post]
